or Try an Advanced Search...

    Technical Analysis for INCR - Intercure Ltd.

    Grade Last Price % Change Price Change
    D 2.03 1.00% 0.02
    INCR closed up 1.0 percent on Monday, July 1, 2024, on 1.23 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Down Down
    Historical INCR trend table...
    Date Alert Name Type % Chg
    Wide Bands Range Expansion 0.00%
    Gapped Up Strength 0.00%
    Oversold Stochastic Weakness 0.00%
    Wide Bands Range Expansion 1.00%
    Gapped Up Strength 1.00%
    Oversold Stochastic Weakness 1.00%
    Wide Bands Range Expansion 3.05%
    Gapped Down Weakness 3.05%
    Oversold Stochastic Weakness 3.05%
    Wide Bands Range Expansion -7.31%
    Older End-of-Day Signals for INCR ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Previous Day's High about 9 hours ago
    Rose Above 10 DMA about 9 hours ago
    Up 5% about 9 hours ago
    Up 3% about 9 hours ago
    Up 2% about 9 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    INCR Chart by TradingView
    Basic chart:

    Profile

    InterCure (dba Canndoc) is the leading cannabis company outside of North America. Canndoc, a wholly owned subsidiary of InterCure, is Israel’s largest licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products. InterCure leverages its market leading distribution network, best in class international partnerships and a high-margin vertically integrated "seed-to-sale" model to maintain its position as Israel’s leading cannabis company as well as to drive further growth through global expansion.
    Classification
    Sector: Healthcare
    Industry: Drug Manufacturers - Specialty & Generic
    Keywords: Cannabis Distribution Network Euphoriants Psychoactive Drugs Entheogens Medicinal Plants Cannabis Smoking Plants

    Is INCR a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 22 InterCure to Participate in Canaccord Genuity’s 8th Annual Global Cannabis Conference
    May 1 InterCure reports FY results
    May 1 InterCure Announces FY2023 Results: Revenue of NIS 356 million and Adjusted EBITDA of NIS 61 million
    Apr 22 InterCure: Bargain Israel Cannabis Play
    Apr 1 InterCure sees annual revenue of NIS 351 million
    Apr 1 InterCure Announces Preliminary Estimated 2023 Revenue of NIS 351 million and EBITDA of over NIS 50 million
    Mar 22 InterCure Congratulates Germany on Cannabis Reform, Expanding its Global Footprint
    Feb 13 InterCure provides update regarding its Nir Oz facility
    Feb 13 InterCure Provides an Update Regarding Nir Oz Facility
    Jan 31 InterCure to buy Isreal-based Leon cannabis pharmacy chain
    See more INCR news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 3.72
    52 Week Low 0.99
    Average Volume 57,514
    200-Day Moving Average 1.87
    50-Day Moving Average 2.76
    20-Day Moving Average 2.32
    10-Day Moving Average 2.14
    Average True Range 0.17
    RSI (14) 32.43
    ADX 32.75
    +DI 12.34
    -DI 28.08
    Chandelier Exit (Long, 3 ATRs) 2.76
    Chandelier Exit (Short, 3 ATRs) 2.46
    Upper Bollinger Bands 2.80
    Lower Bollinger Band 1.84
    Percent B (%b) 0.2
    BandWidth 41.54
    MACD Line -0.22
    MACD Signal Line -0.20
    MACD Histogram -0.0195
    Fundamentals Value
    Market Cap 92.51 Million
    Num Shares 45.6 Million
    EPS 0.12
    Price-to-Earnings (P/E) Ratio 16.92
    Price-to-Sales 0.17
    Price-to-Book 0.50
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.26
    Resistance 3 (R3) 2.27 2.22 2.22
    Resistance 2 (R2) 2.22 2.16 2.21 2.20
    Resistance 1 (R1) 2.12 2.12 2.10 2.11 2.19
    Pivot Point 2.07 2.07 2.05 2.06 2.07
    Support 1 (S1) 1.97 2.01 1.95 1.96 1.87
    Support 2 (S2) 1.92 1.97 1.91 1.86
    Support 3 (S3) 1.82 1.92 1.84
    Support 4 (S4) 1.81